Vistagen Therapeutics, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing innovative therapies for mental health disorders. The company specializes in creating novel treatments that target the underlying biological mechanisms of anxiety, depression, and other related conditions. Vistagen leverages its proprietary drug development platform to advance its pipeline of therapies, aiming to address significant unmet needs in the mental health space and improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

10 Patents

#105 in South San Francisco, CA

#7,121 in California

#29,892 in US

#56,119 in the World

South San Francisco, CA, United States of America

Vistagen Therapeutics, Inc.

Forward Citations = 4

10 inventors:

H Ralph Snodgrass (7 out of 22 patents)

Allen E Cato (6 out of 9 patents)

Jack S Hicklin (6 out of 6 patents)

4. Stefan Abele (2 out of 2 patents)

5. Roland A Breitenmoser (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vistagen Therapeutics, Inc.. Retrieved from https://idiyas.com/company/vistagen-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]